Clinical Trial Update: Cohort Prospective Study of Children With Head and Neck Cystic Malformation Who Are Treated With Intracystic OK432 [Phase 4]

View source ↗

Summary

A Phase 4 prospective cohort study is evaluating intracystic OK-432 for head and neck cystic malformations in children, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Malformation

Drugs mentioned

• OK-432 (Picibanil) (OK-432)

Snippet

Sponsor: Carmel Medical Center | Conditions: CYSTIC MALFORMATION | Phase 4 | Status: UNKNOWN